CD14 and acute myeloid leukemia: Also, within the group of NPM1 mutated samples, which is the largest class of AML, CD14+ Monocyte dominated cases were most resistant to Venetoclax (Fig. S5E, S5F; one-way ANOVA p = 7.6 × 10−4; Supplementary Table S11).